Philippines Health News API

{
    "totalArticles": 101742,
    "articles": [
        {
            "id": "0eceac735f104b9f6ad37f400b993aa8",
            "title": "'Important new treatment option': Finerenone can slow kidney decline in patients without diabetes",
            "description": "\"That amounts to a reduction in risk of approximately 23 percent.\"",
            "content": "A medication already used to treat diabetic kidney disease may soon help a far broader group of patients.\nA new study, published in the peer-reviewed New England Journal of Medicine, suggests that the drug finerenone could benefit people with chronic... [3026 chars]",
            "url": "https://www.yahoo.com/news/science/articles/important-treatment-option-finerenone-slow-072900552.html",
            "image": "https://s.yimg.com/lo/mysterio/api/44698883e5c029b2f6cd6104c9e23d01244859ccf39922a8a877acc5297b6b22/lightyear_networkapi/resizefill_w1200;quality_80;format_webp/https:%2F%2Fmedia.zenfs.com%2Fen%2Fthe_cool_down_737%2F7b459cb11ad8ba9e3ec76e67291789c9",
            "publishedAt": "2026-06-16T07:29:00Z",
            "lang": "en",
            "source": {
                "id": "99e8a2cb4638bb798cf9167e5af5b83b",
                "name": "Yahoo",
                "url": "https://www.yahoo.com"
            }
        },
        {
            "id": "3f500f062cee209271c16337ccd169f6",
            "title": "Adaptive DBS Just Ran a Randomized Trial on Gait. The Endpoints FDA Needs to Validate Next Are Nowhere in Current Guidance.",
            "description": "A Nature Medicine feasibility trial on adaptive deep brain stimulation for Parkinson's gait signals a regulatory gap: FDA has no validated endpoint framework…",
            "content": "A randomized feasibility trial published in Nature Medicine has done something the field of adaptive deep brain stimulation has needed for years: it applied crossover design methodology to evaluate closed-loop DBS against fixed-frequency stimulation ... [6946 chars]",
            "url": "https://www.clinicaltrialvanguard.com/article/intel-brief/adaptive-dbs-just-ran-a-randomized-trial-on-gait-the-endpoints-fda-needs-to-validate-next-are-nowhere-in-current-guidance/",
            "image": "https://www.clinicaltrialvanguard.com/wp-content/uploads/2026/06/adaptive-dbs-just-ran-a-randomized-trial-on-gait-the-endpoin-750x575.png",
            "publishedAt": "2026-06-16T06:53:22Z",
            "lang": "en",
            "source": {
                "id": "adf081adbee2af8312cf0c691f8c3809",
                "name": "The Clinical Trial Vanguard",
                "url": "https://www.clinicaltrialvanguard.com"
            }
        },
        {
            "id": "eef0640f2feeb79157f47a1bf5750a80",
            "title": "Does blood type matter? Why some people are mosquito magnets",
            "description": "Female mosquitoes — which are the only ones that bite — detect these signals with finely-tuned receptors, then choose their target accordingly.",
            "content": "\"It's not a misconception — mosquitoes are attracted to some people more than others,\" Frederic Simard of France's Institute of Research for Development told AFP.\n\"But we are not all magnets all the time,\" the medical entomologist added.\nA range of s... [3496 chars]",
            "url": "https://www.philstar.com/lifestyle/health-and-family/2026/06/16/2535624/does-blood-type-matter-why-some-people-are-mosquito-magnets",
            "image": "https://media.philstar.com/photos/2022/12/15/dengue_2022-12-15_20-59-25.jpg",
            "publishedAt": "2026-06-16T06:28:00Z",
            "lang": "en",
            "source": {
                "id": "762005c2c9a526818f8b84d930946662",
                "name": "Philstar.com",
                "url": "https://www.philstar.com"
            }
        }
    ]
}